Universal Health Services, Inc. (UHS)
NYSE: UHS · IEX Real-Time Price · USD
180.13
+2.43 (1.37%)
May 20, 2024, 12:38 PM EDT - Market open
Universal Health Services Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for UHS stock have an average target of 185.93, with a low estimate of 142 and a high estimate of 226. The average target predicts an increase of 3.22% from the current stock price of 180.13.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UHS stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 9 | 8 | 8 | 7 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 16 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades $189 → $226 | Hold → Strong Buy | Upgrades | $189 → $226 | +25.46% | May 20, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $183 → $189 | Hold | Maintains | $183 → $189 | +4.92% | May 7, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $181 → $183 | Hold | Maintains | $181 → $183 | +1.59% | Apr 30, 2024 |
| Barclays | Barclays | Hold Maintains $181 → $189 | Hold | Maintains | $181 → $189 | +4.92% | Apr 26, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $185 | Hold | Reiterates | $185 | +2.70% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
15.68B
from 14.28B
Increased by 9.76%
Revenue Next Year
16.55B
from 15.68B
Increased by 5.55%
EPS This Year
13.58
from 10.23
Increased by 32.79%
EPS Next Year
15.01
from 13.58
Increased by 10.48%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 16.4B | 17.6B | 18.7B | 18.3B |
| Avg | 15.7B | 16.5B | 17.5B | 17.6B |
| Low | 15.0B | 15.8B | 16.4B | 17.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 14.6% | 12.0% | 13.0% | 4.5% |
| Avg | 9.8% | 5.5% | 5.7% | 0.5% |
| Low | 5.0% | 0.9% | -0.8% | -2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 14.57 | 16.97 | 19.64 | 19.36 |
| Avg | 13.58 | 15.01 | 17.19 | 18.62 |
| Low | 12.69 | 13.41 | 15.78 | 18.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 42.5% | 24.9% | 30.8% | 12.7% |
| Avg | 32.8% | 10.5% | 14.5% | 8.4% |
| Low | 24.1% | -1.3% | 5.1% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.